FDA Should Outsource Elements Of Antibacterial Labeling Updates - Cmte.
Executive Summary
FDA should apply the Clinical and Laboratory Standards Institute's recommendations for updating susceptibility test information in systemic antibacterial drug product labeling, the Anti-Infective Drugs Advisory Committee unanimously recommended
You may also be interested in...
Forest Must Resolve Breakpoint Issues On Road To Ceftaroline Approval
Negotiation of breakpoints appears to be the final hurdle as Forest Laboratories seeks approval for ceftaroline fosamil to treat serious skin infections and community-acquired bacterial pneumonia.
Forest Must Resolve Breakpoint Issues On Road To Ceftaroline Approval
Negotiation of breakpoints appears to be the final hurdle as Forest Laboratories seeks approval for ceftaroline fosamil to treat serious skin infections and community-acquired bacterial pneumonia.
Rep. DeLauro Tries To Block FDA Outsourcing Of Antibiotic Label Updating
FDA's efforts to rely on outside support to carry out its mission have again met with resistance from House Appropriations Subcommittee Chair Rosa DeLauro, D-Conn., who is arguably the agency's most powerful public benefactor